Target intelligence / Profile preview

RAB33B antisense RNA 1 (RAB33B-AS1)

Target
RAB33B-AS1
Molecular classification
Other, Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

RAB33B antisense RNA 1 (RAB33B-AS1) is a long non-coding RNA (lncRNA) gene. It is classified as an antisense RNA because its transcript is complementary to the RAB33B gene (located on the opposite strand), but it does not encode a protein[6][7][9]. Like other natural antisense transcripts, RAB33B-AS1 may regulate RAB33B gene expression through various mechanisms, such as transcriptional interference, RNA duplex formation, or influencing RNA stability, though its specific functions are currently not well characterized in public gene function resources[6][7][9]. There is no information identifying RAB33B-AS1 as a therapeutic drug target, no known drug interactions, biomarker utility, or notable safety/therapeutic challenges. Its roles in physiological or disease processes have not been firmly established in the literature cited by major genomic databases[6][7][9]. \n\n**Note:** \n- RAB33B-AS1 should not be confused with RAB33B, a small GTPase involved in membrane trafficking and autophagy, which is sometimes associated with diseases—but RAB33B-AS1 is a distinct non-protein-coding transcript[6][7][9]. \n- No evidence supports its role as a receptor, enzyme, or other common therapeutic target molecule class. \n- Its biological and clinical significance remains to be clarified in ongoing research.

Other names
RAB33B-AS1
02

Biological functions

Gene regulation (possible, by antisense mechanism or RNA-RNA interaction)Other
03

Disease associations

Other (potential, mechanisms not well described in current databases)

Beyond the preview

Go deeper on RAB33B antisense RNA 1 (RAB33B-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAB33B antisense RNA 1 (RAB33B-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call